Clearing the cognitive cloud: direct oral anticoagulants or vitamin K antagonists for reducing dementia risk in patients with atrial fibrillation?
- 13 October 2021
- Vol. 107 (23), 1854-1855
- https://doi.org/10.1136/heartjnl-2021-320138
Abstract
No abstract availableKeywords
Funding Information
- European Commission (H2020 MAESTRIA 965286)
This publication has 8 references indexed in Scilit:
- Anticoagulant prescribing for atrial fibrillation and risk of incident dementiaHeart, 2021
- Clinical and budget impacts of changes in oral anticoagulation prescribing for atrial fibrillationHeart, 2020
- Adherence and persistence to direct oral anticoagulants in atrial fibrillation: a population-based studyHeart, 2019
- Less dementia and stroke in low-risk patients with atrial fibrillation taking oral anticoagulationEuropean Heart Journal, 2019
- Rationale and design of the impact of anticoagulation therapy on the Cognitive Decline and Dementia in Patients with Nonvalvular Atrial Fibrillation (CAF) Trial: A Vanguard studyClinical Cardiology, 2019
- Incident Atrial Fibrillation, Dementia and the Role of Anticoagulation: A Population-Based Cohort StudyThrombosis and Haemostasis, 2019
- Mild cognitive impairment impacts health outcomes of patients with atrial fibrillation undergoing a disease management interventionOpen Heart, 2018
- Less dementia with oral anticoagulation in atrial fibrillationEuropean Heart Journal, 2017